Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
E-mail: Lynne.Nichols@dh.gsi.gov.uk
NUTS: UK
Internet address(es)
Main address: https://dh.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Contract for the supply of botulism antitoxin heptavalent ((A, B, C, D, E, F, G) — (Equine))
Reference number: CM/EMP/18/327
II.1.2) Main CPV code
33651000
II.1.3) Type of contract
Supplies
II.1.4) Short description
To put in place a contract for a requirement of botulism antitoxin heptavalent ((A, B, C, D, E, F, G) — Equine)).
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
1.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Bedford, UK
II.2.4) Description of the procurement
The provision of Botulism Antitoxin Heptavalent ((A, B, C, D, E, F, G) — (Equine)) for use as part of the stockpile of emergency medicines in response to incidents and business as usual within the NHS.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The works, supplies or services can be provided only by a particular economic operator for the following reason: absence of competition for technical reasons
Explanation
There is only one manufacturer for this required product, therefore using the negotiated procedure without prior publication is justified under Regulation 32(2)(b)(ii) of the Public Contracts Regulations 2015.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
15/06/2018
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Emergent BioSolutions Canada Inc.
Winnipeg
R3T 5Y3
CA
NUTS: 00
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
The contracts is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
VI.4) Procedures for review
VI.4.1) Review body
The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Runcorn
UK
VI.5) Date of dispatch of this notice
13/07/2018